Cancer News and Research

Latest Cancer News and Research

$Cedars-Sinai to develop world's first biological treatment for compression fractures$

Cedars-Sinai to develop world's first biological treatment for compression fractures

A team of physicians and scientists from the Cedars-Sinai Regenerative Medicine Institute and Department of Surgery, led by Dan Gazit, DMD, PhD has been awarded a three-year $1.9 million grant from the California stem cell agency to fund research leading to clinical trials for what could become the first biological treatment for the most common type of bone fracture in osteoporosis patients.

25 Oct 2010

New annual campaign to prevent skin cancer

The annual "Euromelanoma Day" campaign is designed to prevent skin cancer among the general public. While there has been considerable interest, it has proved difficult to reach out to some of the at-risk groups. As such, new ways of encouraging these people to go to a dermatologist are being introduced, reveals research from the University of Gothenburg presented at the dermatologist conference in Sweden.

25 Oct 2010

Valvoline stores raises funds to fight prostate cancer

Several area Valvoline Instant Oil Change service centers are not only changing the oil in cars, but they're also asking customers to consider changing the way they contribute to the fight against prostate cancer.

25 Oct 2010

OncoGenex completes public offering of 3,174,602 units

OncoGenex Pharmaceuticals, Inc. today announced that it has completed a public offering of 3,174,602 units at a price to the public of $15.75 per unit for an aggregate offering amount of $50 million, as previously announced on October 18, 2010.

25 Oct 2010

NCRR awards 450 Recovery Act instrumentation grants to NIH-funded scientists

Leading-edge, shared technologies are an important component of advancing research to improve health. Specialized instruments such as high-powered electron microscopes, high-resolution mass spectrometers and supercomputers that rapidly process vast amounts of data can enable breakthrough discoveries in preventions, treatments and cures for diseases.

22 Oct 2010

Primary care-based patient navigation can reduce healthcare disparities

A new research study conducted by Boston University School of Medicine (BUSM) shows that patient navigation services significantly improve biennial mammography screening rates among inner city women. The results, published online in the Journal of General Internal Medicine, indicate the importance of patient navigation in reducing health disparities in vulnerable patient populations.

22 Oct 2010

Intestinal microbiota can increase broccoli’s cancer-preventive power: Research

A University of Illinois study has shown for the first time that sulforaphane, the powerful cancer-fighting agent in broccoli, can be released from its parent compound by bacteria in the lower gut and absorbed into the body.

22 Oct 2010

Research could lead to new therapies for breast cancers

WORK by scientists in Australia could open the door to a new way of treating certain breast cancers. The disease is now the most common cancer in the UK, with around 125 women in the country diagnosed every day.

22 Oct 2010

Researchers use fruit fly for cancer research

SMALL and with a life cycle of just two weeks, fruit flies are seen by many as pests and a problem all year round. However, for nearly a century, the humble insect, officially known as Drosophila melanogaster, which measures no more than 3mm, has performed a vital role in genetics and developmental biology.Fruit flies are genetically diverse and easy to use in research, helping scientists in a variety of studies, from how the brain functions to how cancer develops.

22 Oct 2010

Bright Starts announces 2010 Pink Power Mom winners

In an ongoing effort to support breast cancer awareness, education and research, Bright Starts announces the winners of its fourth annual Pink Power Mom search. The winners are eight inspirational mothers who have survived (or are currently battling) breast cancer and have used their experience to make a profound difference in the lives of other women affected by the disease

22 Oct 2010

Task Force: Disparities in breast cancer mortality continue to be high in Chicago

Disparities in breast cancer mortality continue to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.

22 Oct 2010

Parents more likely to be dissatisfied with informed consent process in children’s clinical trials

Compared with adult cancer patients, parents of children with cancer were more likely to be dissatisfied with the informed consent process for participating in clinical trials, according to a study from Dana-Farber/Children's Hospital Cancer Center. The findings will be presented at the 42nd Congress of the International Society of Paediatric Oncology (SIOP) in Boston on Saturday, Oct. 23.

22 Oct 2010

Diamyd Medical to divide operations into two business areas

In her comments in today's year end report, Elisabeth Lindner, President and CEO of Diamyd Medical, states that the company has decided to divide its operations into two business areas beginning with the new 2010/2011 fiscal year; Diabetes and Pain.

22 Oct 2010

PSST training helps mothers to cope with stress associated with child's disease

Mothers who have children diagnosed with cancer now have a better approach to address and cope with stresses associated with their child's disease. A new certified intervention has proven to be more effective long term compared to other psychological methods, as reported today at the 42nd Congress of the International Society of Pediatric Oncology.

22 Oct 2010

AACR to host special conference on colorectal cancer

The American Association for Cancer Research will hosts its first special conference on Colorectal Cancer: Biology to Therapy from Oct. 27-30, 2010, at the Loews Hotel, Philadelphia.

22 Oct 2010

Techulon signs license with Virginia Tech Intellectual Properties to market DNA delivery platform

Techulon Inc., a life sciences company based in the Virginia Tech Corporate Research Center, has signed an exclusive license with Virginia Tech Intellectual Properties Inc. to market a new, traceable DNA delivery platform created to deliver genetic medicine to cells while carrying a beacon so scientists can follow its progress.

22 Oct 2010

Disparities in breast cancer mortality continues to be high in Chicago: Data

Disparities in breast cancer mortality continued to be unacceptably high in Chicago and significantly larger than the national average according to new data released today at a rally sponsored by the Metropolitan Chicago Breast Cancer Task Force. The Task Force also announced results of the first year of data collection by the Chicago Breast Cancer Quality Consortium, which found many hospitals in Chicago are not meeting accepted quality standards.

22 Oct 2010

Participants explore role of pediatric oncology nurses at APHON 34th Annual Convention

"While this is a topic most people - even nurses - avoid, it was a most informative presentation for me," said a participant in the session on "The Art of Pediatric Palliative Care Nursing" at the Association of Pediatric Hematology/Oncology Nurses 34th Annual Convention, October 14-16, 2010, in Minneapolis, MN.

22 Oct 2010

New review outlines Bionovo's platform of estrogen receptor modulators for menopausal conditions

Bionovo, Inc. today announced the publication of a review of results from studies discussing new classes of estrogen receptor modulating drugs with distinct mechanism for pharmacological effect. The review is published in the most recent edition of Current Opinion in Pharmacology.

22 Oct 2010

TOBI reduces mortality in patients with cystic fibrosis, Pa lung infection

A new analysis of data from more than 12,000 people with cystic fibrosis (CF) and Pseudomonas aeruginosa (Pa) lung infection in the Cystic Fibrosis Foundation's Patient Registry shows that use of TOBI (Tobramycin Inhalation Solution, USP) was associated with a 21% reduction in mortality in the following year.

22 Oct 2010